Cure Ventures Email Format
Venture Capital and Private Equity PrincipalsMassachusetts, United States11-50 Employees
Cure Ventures is a venture capital and private equity firm based in Boston, Massachusetts, that concentrates on creating new companies around curative technologies. The firm emphasizes de novo company formation, developing ventures around bold ideas and scientists-entrepreneurs. It leverages its team's deep experience in building companies to tailor the amount and type of capital to each stage of a venture's life cycle. The focus is on disruptive scientific solutions with strong intellectual property, aiming to address unmet patient needs and pursue high-impact diseases. In pursuing effective company builds, Cure Ventures looks for ventures with solid genetic validation and rigorously derived scientific data tied to a distinguished laboratory, clear mechanistic biology, and multiple commercial applications. It also prioritizes large, relatively untapped markets, streamlined clinical development pathways, and active partnership interest from large pharmaceutical companies, along with a defined path toward an exit.